You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

afq056

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cocaine Use Disorder Trial (AFQ056, Placebo)

Withdrawn
  • Cocaine Use Disorder
  • AFQ056
  • Placebo
  • (no location specified)
Jun 28, 2021

Cocaine-related Disorder Trial in Argentina, Spain, Switzerland (AFQ056, Placebo)

Completed
Has Results
  • Cocaine-related Disorder
  • AFQ056
  • Placebo
  • Buenos Aires, Argentina
  • +7 more
Oct 7, 2021

Hepatic Impairment Trial in Orlando, Berlin, Balatonfured (AFQ056)

Completed
  • Hepatic Impairment
  • AFQ056
  • Orlando, Florida
  • +2 more
Dec 6, 2020

Mild Moderate, or Severe Renal Impairment Trial in Kiel (AFQ056)

Completed
  • Mild Moderate
  • or Severe Renal Impairment
  • AFQ056
  • Kiel, Germany
    Novartis Investigative Site
Dec 6, 2020

Fragile X Syndrome Trial in Spain, United States (AFQ056)

Completed
  • Fragile X Syndrome
  • AFQ056
  • Sacramento, California
  • +3 more
Dec 6, 2020

Parkinson Disease, Dyskinesia, Drug-Induced, Levodopa Trial in Worldwide (AFQ056)

Completed
  • Parkinson Disease
  • +2 more
  • AFQ056
  • Sunnyvale, California
  • +21 more
Dec 15, 2020

Dyskinesias, Parkinson Disease, Movement Disorders Trial in Worldwide (AFQ056, Placebo)

Completed
  • Dyskinesias
  • +3 more
  • AFQ056
  • Placebo
  • Sunnyvale, California
  • +27 more
Dec 15, 2020

Fragile X Syndrome Trial in Worldwide (AFQ056, Placebo)

Completed
  • Fragile X Syndrome
  • AFQ056
  • Placebo
  • Phoenix, Arizona
  • +30 more
Dec 15, 2020

Dyskinesias, Parkinson Disease, Movement Disorders Trial in Worldwide (AFQ056)

Completed
  • Dyskinesias
  • +4 more
  • AFQ056
  • Englewood, Colorado
  • +31 more
Dec 15, 2020

Dyskinesias, Parkinson Disease, Movement Disorders Trial in Worldwide (AFQ056, Placebo)

Completed
  • Dyskinesias
  • +4 more
  • AFQ056
  • Placebo
  • Sunnyvale, California
  • +38 more
Dec 15, 2020

Parkinson Disease, Dyskinesias Trial in Worldwide (AFQ056, Placebo)

Completed
  • Parkinson Disease
  • Dyskinesias
  • AFQ056
  • Placebo
  • East Gosford, Australia
  • +46 more
Feb 20, 2017

Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses Trial in Worldwide

Terminated
Has Results
  • Patient Diagnosed With OCD and Resistant to SSRI Treatment
  • Failed SSRI Over 12 Weeks at Appropriate Doses
  • AFQ056
  • Placebo
  • San Diego, California
  • +14 more
Nov 15, 2016

Parkinson's Disease, L-dopa Induced Dyskinesia Trial in Germany (AFQ056, Placebo)

Completed
  • Parkinson's Disease
  • L-dopa Induced Dyskinesia
  • AFQ056
  • Placebo
  • Dresden, Germany
  • +4 more
Apr 15, 2016

Fragile X Syndrome Trial in Worldwide (AFQ056)

Terminated
Has Results
  • Fragile X Syndrome
  • AFQ056
  • Phoenix, Arizona
  • +27 more
Apr 11, 2016

Fragile X Syndrome Trial in Worldwide (AFQ056)

Terminated
Has Results
  • Fragile X Syndrome
  • AFQ056
  • Sacramento, California
  • +27 more
Feb 24, 2016

Fragile X Syndrome Trial in Worldwide (AFQ056, Placebo)

Completed
Has Results
  • Fragile X Syndrome
  • AFQ056
  • Placebo
  • Sacramento, California
  • +37 more
May 10, 2015

Huntington's Disease, Chorea Trial in Germany, United Kingdom (AFQ056, Placebo)

Terminated
  • Huntington's Disease
  • Chorea
  • AFQ056
  • Placebo
  • Berlin, Germany
  • +9 more
Sep 22, 2011

Parkinson's Disease Trial in Germany (AFQ056, Placebo)

Completed
  • Parkinson's Disease
  • AFQ056
  • Placebo
  • Dresden, Germany
  • +4 more
May 13, 2010

Gastroesophageal Reflux Disease Trial in Worldwide (AFQ056)

Completed
  • Gastroesophageal Reflux Disease
  • AFQ056
  • Brussels, Belgium
  • +3 more
Jun 21, 2007